Our lab uses frequently uses matrigel for intraperitoneal injection of ovarian/endometrial tumour cells. However, there is no literature I can find that describes the use of matrigel with IP injections, and it is only recommended for orthotopic and subcutaneous injections.
Intraperitoneal injection is more like a metastatic model and so it seems as though the formation of a matrigel plug is counter-intuitive.
Should I stick to just using PBS? Or should it not really matter?
Edit:
Thank you for all your answers so far! I would like to add that with gynecological cancers, direct spread to the peritoneal cavity is very common; metastasis via the blood stream not so much. That's why we inject tumour cells intraperitoneally.